Tecan’s Infinite® offers the MIDAS touch
Publication date: 8 April 2010
Author:
Tagged with: Avacta Group, Ed Quinn, Russell Hodgetts, Tecan
Avacta Group in York, UK, has chosen Tecan’s Infinite M200 microplate reader to play a pivotal role in offering innovative analytical services to the biopharmaceutical sector, where high quality and reproducible data acquisition is crucial.
Russell Hodgetts, MD of Avacta’s Laboratory Services, explained: “The Infinite M200 allows us to provide quality, high throughput services to our clients, and is integral to the development of solubility screening assays, which are the starting point for our formulation development service. The multiple detection methods and environmental control available with the Tecan instrument make it extremely versatile.”
Avacta has recently developed MIDAS (multi immuno diagnostic assay system), a point-of-care platform designed to automate medical diagnostic tests usually performed manually in a laboratory. The Infinite plate reader has been central to this bioassay development, as Product Manager Dr Ed Quinn, explained: “The multimode detection capabilities of the Infinite reader allow us to carry out a wide range of assaying techniques – using absorbance, fluorescence and luminescence detection – on one instrument, and the built-in temperature control and shaking mean that the complete assay can be performed in situ. The easy-to-use i¬control™ software allows us to rapidly set up experiments, defining our own plate parameters to improve the resolution of our assays. Data is automatically exported to our laboratory information system, seamlessly integrating into our research and development program.”
To find out more on Tecan’s Infinite M200 reader, visit www.tecan.com/infinite200
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content